IP Library Granted Patent US 8,043,859
Granted Patent B2
US 8,043,859 · App. 12/821,916 · Granted Oct 25, 2011

Quality control mixture for glycine tablets, a method for preparing the mixture and a method for identifying the mixture

Assignee: Nekommercheskoe Uchrezhdenie “Nauchno-Issledovateljskiyj Institut Citokhimii I Molekulyarnoyj Farmakologii”
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,043,859
App. No.
12/821,916
Granted
Oct 25, 2011
Kind
B2
Abstract

A method is described for preparing a mixture for quality control of 0.1 g glycine tablets for sublingual application. The mixture for quality control includes a 100:0.5 ratio of ethanol to porphyrized tablets, each tablet containing 0.1 g microcapsules of non-agglomerated crystals of amino-acetic acid covered with a polymeric film of water-soluble methylcellulose, each tablet further containing 0.001 g of magnesium stearate. The process for preparing the mixture includes dissolution of the tablet in ethanol for 20 minutes and is carried out at a temperature of 40° C. in an apparatus using a paddle rotation speed of 200 revolutions per minute. After the mixture is dissolved, it is allowed to stand for 10 minutes at room temperature, and then a light transmission coefficient is measured at 700±2 nm for a 10 mm thick layer of the mixture. A transmission value within the limits of 90% to 100% compared with 50% ethanol corresponds to the proper quality.

Claims (12)

1. A mixture for quality control of 0.1 g glycine tablets for sublingual application, the tablets having stress-preventative, anti-stress, nootropic and neuroprotective effects, the tablets being suitable for single administration or for long-term treatment, each tablet comprising microcapsulated glycine comprising non-agglomerated crystals of amino-acetic acid covered with a polymeric film of water-soluble methycellulose, each tablet further comprising magnesium stearate and each tablet having a crush resistance ranging from 10 to 30 N and a decomposition period varying from 10 to 20 minutes, the mixture comprising:

50% ethanol and the 0.1 g glycine tablets that have been porphyrized in a ratio of 100:0.5, wherein a sample of 4 ml of the mixture with a layer thickness of 10 mm has a light transmission coefficient at a wavelength of 700±2 nm in comparison with 50% ethanol within the limits of 90% to 100%.

2. A method of preparing a mixture for quality control of 0.1 g glycine tablets for sublingual application, the tablets having stress-preventative, anti-stress, nootropic and neuroprotective effects, the tablets being suitable for single administration or for long-term treatment, each tablet comprising microcapsulated glycine comprising non-agglomerated crystals of amino-acetic acid covered with a polymeric film of water-soluble methycellulose, each tablet further comprising magnesium stearate and each tablet having a crush resistance ranging from 10 to 30 N and a decomposition period varying from 10 to 20 minutes, the method comprising:

providing said tablets that have been porphyrized;

obtaining the mixture by mixing 1.25 g of porphyrized tablets in 250 ml of 50% ethanol for 20 minutes at a temperature of 40° C. in an apparatus using a paddle rotation speed of 200 revolutions per minute;

allowing the mixture to stand for 10 minutes at room temperature;

and measuring a light transmission coefficient of 4 ml of the mixture for a 10 mm thick layer in a container relative to the light transmission coefficient for 50% ethanol using a light transmission spectrophotometer at a wavelength of 700±2 nm.

3. A method for performing an identification test for quality control of 0.1 g glycine tablets for sublingual application, the tablets having stress-preventative, anti-stress, nootropic and neuroprotective effects, the tablets being suitable for single administration or for long-term treatment, each tablet comprising microcapsulated glycine comprising non-agglomerated crystals of amino-acetic acid covered with a polymeric film of water-soluble methycellulose, each tablet further comprising magnesium stearate and each tablet having a crush resistance ranging from 10 to 30 N and a decomposition period varying from 10 to 20 minutes, the method comprising:

preparing a hydro-alcohol mixture by dissolving 1.25 g of the 0.1 g glycine tablets which have been porphyrized in 250 ml of 50% ethanol for 20 minutes at a temperature of 40° C. in an apparatus using a paddle rotation speed of 200 revolutions per minute; allowing the mixture to stand for 10 minutes at room temperature; and measuring a light transmission coefficient of 4 ml of the hydro-alcohol mixture for a 10 mm thick layer in a container relative to the light transmission coefficient for 50% ethanol using a light transmission spectrophotometer at a wavelength of 700±2 mm;

preparing a water mixture by dissolving 2.5 g of the 0.1 g glycine tablets which have been porphyrized in 250 ml of purified water for 20 minutes at a temperature of 37° C. in an apparatus using a paddle rotation speed of 150 revolutions per minute; allowing the mixture to stand for 10 minutes at room temperature; and measuring a light transmission coefficient of 4 ml of the water mixture for a 10 mm thick layer in a container relative to the light transmission coefficient for purified water using a light transmission spectrophotometer at a wavelength of 700±2 nm;

determining the difference between the light transmission coefficients of the hydroalcohol mixture and the water mixture; and

comparing the difference with a limit of 30 to 50%.

Assignments (2)
CHANGE OF NAME Recorded Dec 29, 2014
From: NEKOMMERCHESKOE UCHREZHDENIE "NAUCHNO-ISSLEDOVATELJSKIYJ INSTITUT CITOKHIMII I MOLEKULYARNOYJ FARMAKOLOGII"
To: CHASTNOE UCHREZHDENIE "NAUCHNO-ISSLEDOVATELJSKIYJ INSTITUT CITOKHIMII I MOLEKULYARNOYJ FARMAKOLOGII"
Reel/Frame 034708/0245 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2010
From: KOMISSAROVA, IRINA A.; SOLDATENKOVA, TATJYANA D.; GUDKOVA, YULIYA V.; KONDRASHOVA, TATJYANA T.; BURBENSKAYA, NATALJYA M.
To: NEKOMMERCHESKOE UCHREZHDENIE "NAUCHNO-ISSLEDOVATELJSKIYJ INSTITUT CITOKHIMII I MOLEKULYARNOYJ FARMAKOLOGII"
Reel/Frame 025083/0709 →
Priority Claims (1)
RU 200700597 · Mar 7, 2007 · national
Continuity (2)
Continuation PCTRU2008000130 · Mar 6, 2008
Related Publication 20110014711A1 · Jan 20, 2011